Search Legislation

Advanced Search

The Blood Safety and Quality Regulations 2005

Changes to legislation:

There are currently no known outstanding effects for the The Blood Safety and Quality Regulations 2005. Help about Changes to Legislation

Close

Changes to Legislation

Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.

  1. Introductory Text

  2. 1.Citation, commencement and interpretation

  3. 1A.Modification of provisions of the Annex to Commission Directive 2005/62/EC

  4. 1B.References to the requirements set out in the Annex to Commission Directive 2005/62/EC

  5. 2.Designation of the competent authority for Northern Ireland and scope of the Regulations

  6. 3.Requirement for authorisation

  7. 4.Authorisation of a blood establishment

  8. 5.Suspension or revocation of authorisation

  9. 6.The responsible person for a blood establishment

  10. 7.Blood establishment requirements

  11. 8.Labelling of blood and blood components and traceability

  12. 9.Hospital blood bank requirements

  13. 10.Requirement for hospital blood banks to provide information to the Secretary of State

  14. 11.Service of notices relating to hospital blood banks

  15. 12.Objections to suspensions, revocations etc

  16. 12A.Requirement that facilities retain certain data

  17. 12B.Requirement to report serious adverse reactions and events

  18. 13.Import of blood and blood components into Great Britain

  19. 13A. Import of blood and blood components into Northern Ireland

  20. 14.Disclosure of information by blood establishments and hospital blood banks

  21. 15.Inspections, etc.

  22. 16.Records to be kept by the Secretary of State

  23. 16A.Requirement that the Secretary of State communicate certain information in respect of Northern Ireland to other competent authorities

  24. 17.Powers of entry, etc.

  25. 18.Criminal offences

  26. 19.Penalties

  27. 20.Defence of due diligence

  28. 21.Offences by bodies corporate and Scottish partnerships

  29. 22.Fees

  30. 23.Specific epidemiological situations in relation to Great Britain

  31. 23ZA.Specific epidemiological situations in relation to Northern Ireland

  32. 23A.Regulations relating to the quality and safety of blood and blood components

  33. 23B.Scope and nature of powers

  34. 23C.Scrutiny of regulations made by the Secretary of State

  35. 23D.Scrutiny of regulations made by the Welsh Ministers

  36. 23E.Scrutiny of regulations made by the Scottish Ministers

  37. 23F.. . . . . . . . . ....

  38. 24.Transitional provisions

  39. 25.Consequential amendments

  40. Signature

    1. SCHEDULE

      1. PART 1

        1. Definitions

        2. 1.“Autologous donation” means blood and blood components collected from an...

        3. 2.“Allogeneic donation” means blood and blood components collected from an...

        4. 3.“Whole blood” means a single blood donation.

        5. 4.“Cryopreservation” means prolongation of the storage life of blood components...

        6. 5.“Plasma” means the liquid portion of the blood in which...

        7. 6.“Cryoprecipitate” means a plasma component prepared from plasma, fresh-frozen, by...

        8. 7.“Washed” means a process of removing plasma or storage medium...

        9. 8.“Red cells” means the red cells from a single whole...

        10. 9.“Red cells, buffy coat removed” means the red cells from...

        11. 10.“Red cells, leucocyte-depleted” means the red cells from a single...

        12. 11.“Red cells in additive solution” means the red cells from...

        13. 12.“Additive solution” means a solution specifically formulated to maintain beneficial...

        14. 13.“Red cells, buffy coat removed, in additive solution” means the...

        15. 14.“Buffy coat” means a blood component prepared by centrifugation of...

        16. 15.“Red cells, leucocyte-depleted, in additive solution” means the red cells...

        17. 16.“Red cells, apheresis” means the red cells from an apheresis...

        18. 17.“Apheresis” means a method of obtaining one or more blood...

        19. 18.“Platelets, apheresis” means a concentrated suspension of blood platelets obtained...

        20. 19.“Platelets, apheresis, leucocyte-depleted” means a concentrated suspension of blood platelets,...

        21. 20.“Platelets, recovered, pooled” means a concentrated suspension of blood platelets,...

        22. 21.“Platelets, recovered, pooled, leucocyte-depleted” means a concentrated suspension of blood...

        23. 22.“Platelets, recovered, single unit” means a concentrated suspension of blood...

        24. 23.“Platelets, recovered, single unit, leucocyte-depleted” means a concentrated suspension of...

        25. 24.“Plasma, fresh-frozen” means the supernatant plasma separated from a whole...

        26. 25.“Plasma, cryoprecipitate-depleted for transfusion” means a plasma component prepared from...

        27. 26.“Granulocytes, apheresis” means a concentrated suspension of granulocytes obtained by...

        28. 27.“Statistical process control” means a method of quality control of...

      2. PART 2 INFORMATION REQUIREMENTS FOR DONORS

        1. Part A – Information to be provided to prospective donors of blood or blood components

        2. 1.Accurate educational materials, which are written in terms which can...

        3. 2.For both allogeneic and autologous donations, the reasons for requiring...

        4. 3.For allogeneic donations, the criteria for self-deferral, and temporary and...

        5. 4.For autologous donations, the possibility of deferral and the reasons...

        6. 5.Information on the protection of personal data, including confirmation that...

        7. 6.The reasons why individuals are not to make donations which...

        8. 7.Specific information on the nature of the procedures involved either...

        9. 8.Information on the option for donors to change their mind...

        10. 9.The reasons why it is important that donors inform the...

        11. 10.Information on the responsibility of the blood establishment to inform...

        12. 11.Information as to why unused autologous blood and blood components...

        13. 12.Information that test results detecting markers for viruses, such as...

        14. 13.Information on the opportunity for donors to ask questions at...

        15. Part B – Information to be obtained from donors by blood establishments at every donation

        16. 14.Identification of the donor

        17. 15.Health and medical history of the donor

        18. 16.Signature of the donor

      3. PART 3 ELIGIBILITY CRITERIA FOR DONORS OF WHOLE BLOOD AND BLOOD COMPONENTS

        1. 1.Acceptance criteria for donors of whole blood and blood components

        2. 1.1.Age and body weight of donors Age 18 to 65...

        3. 1.2.Haemoglobin levels in donor's blood Haemoglobin For females ≥ 125...

        4. 1.3.Protein levels in donor's blood Protein ≥ 60 g/l The...

        5. 1.4.Platelet levels in donor's blood Platelets Platelet number greater than...

        6. 2.1.Deferral criteria for donors of whole blood and blood components

        7. 2.2.Temporary deferral criteria for donors of allogeneic donations

        8. 2.2.1.Infections

        9. Duration of deferral period

        10. However, the following deferral periods shall apply for the infections...

        11. 2.2.2.Exposure to risk of acquiring a transfusion-transmissible infection — Endoscopic...

        12. 2.2.3.Vaccination Attenuated viruses or bacteria 4 weeks Inactivated/killed viruses, bacteria...

        13. 2.2.4.Other temporary deferrals Pregnancy 6 months after delivery or termination,...

        14. 2.3.Deferral for particular epidemiological situations Particular epidemiological situations (e.g. disease...

        15. 2.4.Deferral criteria for donors of autologous donations Serious cardiac disease...

      4. PART 4 STORAGE, TRANSPORT AND DISTRIBUTION CONDITIONS FOR BLOOD AND BLOOD COMPONENTS

        1. 1.STORAGE

        2. 1.1.Liquid storage Component Temperature of storage Maximum storage time Red...

        3. 1.2.Cryopreservation Component Storage conditions and duration Red blood cells Up...

        4. 2.TRANSPORT AND DISTRIBUTION

        5. 3.ADDITIONAL REQUIREMENTS FOR AUTOLOGOUS DONATIONS

        6. 3.1.Autologous blood and blood components must be clearly identified as...

        7. 3.2.Autologous blood and blood components must be labelled as required...

      5. PART 5 QUALITY AND SAFETY REQUIREMENTS FOR BLOOD AND BLOOD COMPONENTS

        1. 1.THE BLOOD COMPONENTS 1. Red cell preparations The components listed...

        2. 2.QUALITY CONTROL REQUIREMENTS FOR BLOOD AND BLOOD COMPONENTS

        3. 2.1.Blood and blood components must comply with the following technical...

        4. 2.2.Appropriate bacteriological control of the collection and manufacturing process must...

        5. 2.3.For autologous donations, the measures marked with an asterisk (*)...

      6. PART 6 RECORD OF DATA ON TRACEABILITY

        1. A. BY BLOOD ESTABLISHMENTS

          1. 1.Blood establishment identification

          2. 2.Blood donor identification

          3. 3.Blood unit identification

          4. 4.Individual blood component identification

          5. 5.Date of collection (year/month/day)

          6. 6.Facilities to which blood units or blood components are distributed,...

        2. B. BY FACILITIES

          1. 1.Blood component supplier identification

          2. 2.Issued blood component identification

          3. 3.Transfused recipient identification

          4. 4.For blood units not transfused, confirmation of subsequent disposition

          5. 5.Date of transfusion or disposition (year/month/day)

          6. 6.Lot number of the component, if relevant.

      7. PART 7 NOTIFICATION OF SERIOUS ADVERSE REACTIONS

        1. SECTION A Rapid notification format for suspected serious adverse reactions

        2. SECTION B Serious adverse reactions – imputability levels

        3. SECTION C Confirmation format for serious adverse reactions

        4. SECTION D Annual notification format for serious adverse reactions

      8. PART 8 NOTIFICATION OF SERIOUS ADVERSE EVENTS

        1. SECTION A Rapid Notification Format for Serious Adverse Events

        2. SECTION B Confirmation Format for Serious Adverse Events

        3. SECTION C Annual Notification Format for Serious Adverse Events

  42. Explanatory Note

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

Explanatory Memorandum

Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as enacted version that was used for the print copy
  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Timeline of Changes

This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.

Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as made version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources